SCHEMBL26648263

SCHEMBL26648263

N#Cc1ccc(C(CO)NC(=O)O)cc1

nearest known ligand 0.46

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.46
GAA P10253 1/20 0.46
MAPT P10636 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
EEF2K O00418 1/20 0.45
HTT P42858 1/20 0.43
GSK3B P49841 2/20 0.42
EPHX2 P34913 1/20 0.42
RIPK1 Q13546 1/20 0.41
GPR88 Q9GZN0 5/20 0.40
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
CYP2D6 P10635 1/20 0.40
CYP2C9 P11712 1/20 0.40
SLC6A9 P48067 1/20 0.40
SLC6A5 Q9Y345 1/20 0.40
EGLN1 Q9GZT9 2/20 0.39
F2R P25116 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26648261 1.00 KDM4E (0.46) KDM4EGAAMAPTL3MBTL1EEF2K
SCHEMBL20446262 0.81 RIPK1 (0.43) EEF2KGSK3BEPHX2RIPK1GPR88
SCHEMBL20446264 0.81 RIPK1 (0.43) EEF2KGSK3BEPHX2RIPK1GPR88
SCHEMBL321238 0.81 KDM4E (0.47) KDM4EGAAMAPTL3MBTL1EEF2K
SCHEMBL25295634 0.79 LMNA (0.51) EPHX2RIPK1GPR88MEN1KMT2A
SCHEMBL21839155 0.79 RIPK1 (0.45) GSK3BEPHX2RIPK1GPR88
SCHEMBL15912993 0.79 MAPT (0.46) KDM4EGAAMAPTL3MBTL1EEF2K
SCHEMBL25295633 0.79 LMNA (0.51) EPHX2RIPK1GPR88MEN1KMT2A
SCHEMBL25353842 0.79 RIPK1 (0.45) GSK3BEPHX2RIPK1GPR88
SCHEMBL15229201 0.79 RIPK1 (0.45) GSK3BEPHX2RIPK1GPR88

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023220425-A1 BCL-XL/BCL-2 DEGRADERS AND USES THEREOF KYMERA THERAPEUTICS, INC. (US) 2023-11-16 WO disclosed